|
Shanghai Soho-Yiming Pharmaceuticals Co., Ltd.
|
Shanghai Soho-Yiming Pharmaceuticals Co., Ltd. ( SHYM-Pharma ), formerly known as Shanghai Zillion Pharmaceuticals Co., Ltd., is a high-tech enterprise located in Shanghai, China. With well equipped laboratory and experienced staff, SHYM-Pharma is dedicated to R&D, manufacturing and marketing of the peptide synthesis field. Established in 2001, through years of development, it has now become a leading manufacturer in the peptide synthesis field of China who can offer a wide variety of peptides from milligram up to kilogram with good quality and competitive price that you might require for commercialization.
Our Facilities:
|
Send Inquiry
|
|
Sinoway Industrial Co.Ltd.
|
|
Product name
|
THYMOPENTIN
|
|
Molecular Formula
|
C30H49N9O9
|
|
Molecular Weight
|
268.93
|
|
CAS No.
|
69558-55-0
|
|
Quality Standard
|
99% up, medical grade
|
|
Appearance
|
White powder
|
|
Sequence
|
Arg-Lys-Asp-Val-Tyr-NH2
|
|
Character
|
Composed of arginine, lysine, aspartic acid, tyrosine and valine amino acid
|
|
Test Item
|
Specification
|
Results
|
|
Appearance
|
White to off-white powder
|
Off-white powder
|
|
Solubility
|
Very soluble in water, slightly soluble in ethanol, insoluble in ethyl acetate, ether and petroleum ether
|
Conform
|
|
Specific rotation
|
-14.0o ~ -22.0o
|
-16.5o
|
|
Biuret reaction
|
Should appear positive reaction
|
Positive reaction
|
|
IR
|
Infrared spectrogram should conform to reference substance
|
Conform
|
|
HPLC
|
Retention time of main peak of test sample should be consistent with reference substance
|
Conform
|
|
pH
|
7.0-9.0
|
8.1
|
|
Water
|
NMT 5.0%
|
2.6%
|
|
Amino acids
|
Arg 0.8-1.2
Asp 0.8-1.2
Lys 0.8-1.2
Tyr 0.8-1.2
Val 0.8-1.2
|
Conform
|
|
Related substance
|
Single impurity NMT 1.5%
Total impurity NMT 2.5%
|
0.2%
0.3%
|
|
Bacterial endotoxin
|
< 5EU/mg
|
Conform
|
|
Assay
|
97.0% - 103.0%
|
101.1%
|
|
Conclusion
|
It conforms to the enterprise standard
|
Introduction of Thymopentin 69558-55-0:
Pharmacological effects:
Cell immunoregulatory drugs, can induce T cell differentiation and promote the development of T lymphocyte subsets, mature and activation function, and to adjust the proportion of lymphocyte subsets, it close to normal.
Indications:
Can be used to improve the radiotherapy and chemotherapy for cancer patients immunocompromised result. It can normalize and prevent all kinds of cellular immune deficiency to some extent and thus a potential immune modulating agents. |
Send Inquiry
|
|
Sinoway Industrial Co.Ltd.
|
Product name
|
THYMOPENTIN
|
Molecular Formula
|
C30H49N9O9
|
Molecular Weight
|
268.93
|
CAS No.
|
69558-55-0
|
Quality Standard
|
99% up, medical grade
|
Appearance
|
White powder
|
Sequence
|
Arg-Lys-Asp-Val-Tyr-NH2
|
Character
|
Composed of arginine, lysine, aspartic acid, tyrosine and valine amino acid
|
Test Item
|
Specification
|
Results
|
Appearance
|
White to off-white powder
|
Off-white powder
|
Solubility
|
Very soluble in water, slightly soluble in ethanol, insoluble in ethyl acetate, ether and petroleum ether
|
Conform
|
Specific rotation
|
-14.0o ~ -22.0o
|
-16.5o
|
Biuret reaction
|
Should appear positive reaction
|
Positive reaction
|
IR
|
Infrared spectrogram should conform to reference substance
|
Conform
|
HPLC
|
Retention time of main peak of test sample should be consistent with reference substance
|
Conform
|
pH
|
7.0-9.0
|
8.1
|
Water
|
NMT 5.0%
|
2.6%
|
Amino acids
|
Arg 0.8-1.2
Asp 0.8-1.2
Lys 0.8-1.2
Tyr 0.8-1.2
Val 0.8-1.2
|
Conform
|
Related substance
|
Single impurity NMT 1.5%
Total impurity NMT 2.5%
|
0.2%
0.3%
|
Bacterial endotoxin
|
< 5EU/mg
|
Conform
|
Assay
|
97.0% - 103.0%
|
101.1%
|
Conclusion
|
It conforms to the enterprise standard
|
Introduction of Thymopentin 69558-55-0:
Pharmacological effects:
Cell immunoregulatory drugs, can induce T cell differentiation and promote the development of T lymphocyte subsets, mature and activation function, and to adjust the proportion of lymphocyte subsets, it close to normal.
Indications:
Can be used to improve the radiotherapy and chemotherapy for cancer patients immunocompromised result. It can normalize and prevent all kinds of cellular immune deficiency to some extent and thus a potential immune modulating agents. |
Send Inquiry
|
Pharma Sources Insight June 2024: Globalization on the Go
